4
Changes in Ownership
Phathom Pharmaceuticals, Inc. Filed Acc 0001209191-22-048472
President and Chief Executive acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Curran Terrie President and Chief Executive | 2022-09-01 | Grant or award | +7,500 | 85,246 | D |
Loading xslF345X03/doc4.xml…